Mural Financial Statements From 2010 to 2025

MURA Stock   3.66  0.07  1.88%   
Mural Oncology financial statements provide useful quarterly and yearly information to potential Mural Oncology plc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mural Oncology financial statements helps investors assess Mural Oncology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mural Oncology's valuation are summarized below:
Market Capitalization
63.6 M
Earnings Share
(7.58)
We have found one hundred six available fundamental ratios for Mural Oncology, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mural Oncology last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Enterprise Value is expected to grow to about (50.2 M)
Check Mural Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mural Oncology's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 2 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.41. Mural financial statements analysis is a perfect complement when working with Mural Oncology Valuation or Volatility modules.
  
Check out the analysis of Mural Oncology Correlation against competitors.

Mural Oncology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets148.5 M169.4 M67.2 M
Slightly volatile
Short and Long Term Debt Total13.5 MM22.5 M
Slightly volatile
Other Current Liabilities18.5 M18.6 M12.8 M
Slightly volatile
Total Current Liabilities26 M26.2 M32.6 M
Slightly volatile
Property Plant And Equipment Net19.7 M14.5 M28.6 M
Slightly volatile
Accounts PayableM2.1 M8.7 M
Slightly volatile
Non Current Assets Total20.1 M16.5 M28.8 M
Slightly volatile
Common Stock Shares Outstanding18.4 M17 M16.8 M
Slightly volatile
Liabilities And Stockholders Equity148.5 M169.4 M67.2 M
Slightly volatile
Non Current Liabilities Total2.6 M2.7 M16.6 M
Slightly volatile
Capital Lease Obligations13.5 MM22.5 M
Slightly volatile
Other Current Assets5.1 M8.5 M4.4 M
Pretty Stable
Total Liabilities35 M28.9 M49.6 M
Slightly volatile
Property Plant And Equipment Gross46.1 M51.5 M59 M
Slightly volatile
Total Current Assets120.8 M152.9 M37.9 M
Slightly volatile
Non Current Liabilities Other238.7 K211.5 K328.8 K
Slightly volatile
Short Term Debt8.3 M5.6 M11.2 M
Slightly volatile
Non Currrent Assets Other1.2 MM426.3 K
Slightly volatile
Net Receivables48.5 K51 K4.9 M
Slightly volatile
Inventory120 K135 K147.2 K
Slightly volatile
Other Stockholder Equity326.8 M299.7 M296.9 M
Slightly volatile
Common Stock185.9 K171 K168.4 K
Slightly volatile

Mural Oncology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And AmortizationMM1.7 M
Slightly volatile
Selling General Administrative27.2 M27.6 M18.6 M
Slightly volatile
Other Operating Expenses207.2 M223.8 M182.8 M
Slightly volatile
Research Development120.5 M110.7 M155.1 M
Slightly volatile
Cost Of RevenueMM1.7 M
Slightly volatile
Total Operating Expenses140.2 M138.3 M173.1 M
Slightly volatile
Reconciled Depreciation2.5 M3.5 M1.7 M
Slightly volatile

Mural Oncology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation4.8 M5.1 M11.5 M
Very volatile
Other Cashflows From Financing Activities186.2 K196 K161 M
Very volatile
Depreciation2.5 M3.5 M1.7 M
Slightly volatile
Capital Expenditures87.4 K92 K3.9 M
Slightly volatile
Total Cash From Financing Activities186.2 K196 K161 M
Very volatile
Change To Account Receivables4.4 M4.9 M5.4 M
Slightly volatile
Other Cashflows From Investing Activities53.6 K60.3 K65.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.02490.02622.5421
Slightly volatile
Payables Turnover0.290.390.2062
Slightly volatile
Days Payables Outstanding1.5 K9772.2 K
Slightly volatile
Income Quality0.741.00020.8926
Very volatile
Current Ratio3.135.83761.2607
Slightly volatile
Capex Per Share0.00520.00540.2313
Slightly volatile
Interest Debt Per Share0.450.47311.3238
Slightly volatile
Debt To Assets0.0450.04740.5854
Slightly volatile
Days Of Payables Outstanding1.5 K9772.2 K
Slightly volatile
Ebt Per Ebit0.80.90.9842
Slightly volatile
Quick Ratio3.135.83761.2607
Slightly volatile
Net Income Per E B T0.820.960.992
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.00071.0317
Pretty Stable
Debt Ratio0.0450.04740.5854
Slightly volatile

Mural Oncology Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap56 M54.6 M64.6 M
Pretty Stable

Mural Fundamental Market Drivers

Cash And Short Term Investments144.4 M

Mural Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Mural Oncology Financial Statements

Mural Oncology stakeholders use historical fundamental indicators, such as Mural Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mural Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mural Oncology's assets and liabilities are reflected in the revenues and expenses on Mural Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mural Oncology plc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of RevenueMM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:
Check out the analysis of Mural Oncology Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.58)
Return On Assets
(0.85)
Return On Equity
(1.84)
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.